Skip to main content

Lɛ wi lan bɔt di Pembrolizumab vaysin we dɛn kin yuz fɔ mɛn kansa.

Lɛ wi lan bɔt di Pembrolizumab vaysin we dɛn kin yuz fɔ mɛn kansa.

We yu kam fɔ no se yu ɔ pɔsin we de nia yu gɛt kansa, i nɔmal fɔ mek yu want fɔ no mɔ bɔt di tritmɛnt dɛn we yu go gɛt, ɛn sɔntɛm yu go ivin fred. I kin mek yu fred, mɔ we yu yɛri bɔt nyu, kɔmplikɛt mɛrɛsin dɛn. Tide wi go tɔk bɔt wan pan dɛn kayn nyu kansa tritmɛnt ya, Pembrolizumab. Lɛ wi tɔk simpul ɛn padi biznɛs bɔt wetin rili de apin ɛn wetin wi nid fɔ no bɔt.

Wetin na Pembrolizumab?

Fɔ tɔk am simpul wan, Pembrolizumab na wan mɛrɛsin we dɛn kin yuz fɔ mɛn sɔm patikyula kayn kansa . Dɛn kɔl am na di makit as ``Keytruda``. dis nכ lεk rεgulεr drog, i de pan wan tכp ``monoclonal antibodi``.

Imajin, wi yon bɔdi gɛt ami we de protɛkt wi frɔm sik, wi de kɔl am di imyun sistɛm. Sɔntɛnde, kansa sɛl dɛn kin rili kɔni, dɛn kin ayd frɔm dis imyun ami. Wetin Pembrolizumab de du na fɔ gi wi imyun sistɛm wan signal, "Wek, ɛnimi de ya," ɛn ɛp am fɔ fɛn kansa sɛl dɛn ɛn atak dɛn. Dat min se na we fɔ yuz wi yon difens sistɛm fɔ fɛt kansa.

Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu bigin tritmɛnt

I rili impɔtant fɔ tɛl yu dɔktɔ bɔt yu kɔmplit wɛlbɔdi histri, bikɔs dis mɛrɛsin nɔr de di sem fɔ ɔlman. Mek shɔ se yu tɛl yu dɔktɔ bɔt dɛn tin ya mɔ:

  • Sik dɛm wae de mek yu imyun sistɛm: If yu gɛt sik dɛm wae de mek yu ebul fɔ fɛt yusɛf, lɛk Crohn’s disease, ulcerative colitis, ɔ lupus, we di bɔdi in imyun sistɛm de atak in yon sɛl dɛm.
  • Ɔgan transplant: If yu dɔn gɛt ɔgan transplant bifo ɔ if yu dɔn gɛt ɔ yu de plan fɔ gɛt allogeneic stem cell transplant.
  • Ɔda mɛrɛsin dɛn: If yu dɔn gɛt raytin tritmɛnt to di chɛst eria, ɔ if yu gɛt wan sik we de na yu nervɔs sistɛm, lɛk myasthenia gravis ɔ Guillain-Barre syndrome.
  • Alɛji: If yu gɛt alɛji to dis mɛrɛsin, Pembrolizumab, ɔ ɛni ɔda mɛrɛsin, it, ɔ day.
  • Bεlε εn bεlε: If yu bεlε, yu de tray fכ bεlε, כ yu de gi pikin bεlε, i fayn fכ tεl yu dכkta. Dis rili impɔtant.

Aw a go gi yu dis mɛrɛsin?

Dis mɛrɛsin nɔto sɔntin we yu kin kɛr go na os.

dis na `infushכn` we dεn de gi insay wan vein, lεk salin. Dat min se na di mɛdikal wokman dɛn we tren na ɔspitul ɔ klinik de gi yu.

Bifo ɛni tritmɛnt sɛshɔn, dɛn go gi yu wan spɛshal infɔmeshɔn liflet (MedGuide) bɔt dis mɛrɛsin. I rili impɔtant fɔ mek yu sef fɔ rid ɛn ɔndastand am gud gud wan ɔltɛm.

Dɛn kin advays dis mɛrɛsin bak fɔ pikin dɛn we dɔn pas 6 mɔnt pan sɔm spɛshal kes dɛm. Bɔt yu fɔ tek tɛm spɛshal, so tek tɛm tɔk bɔt am wit yu dɔktɔ.

Wetin a go du if a tek bɔku mɛrɛsin?

Dis na ɔspitul mɛrɛsin, so di chans fɔ mek dis apin nɔ bɔku. Bɔt if yu tink se yu dɔn tek dis mɛrɛsin tumɔs, go na ɔspitul in Imejɛnsi Yunit (ETU) wantɛm wantɛm . Ɔ kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital fɔ advays.

Wetin a go du if a mis wan tritmɛnt sɛshɔn?

I rili impɔtant fɔ tek dis mɛrɛsin di de ɛn tɛm we dɛn dɔn sɛtul. If yu nɔ ebul fɔ go na ɔspitul di de we dɛn dɔn plan fɔ go, kɔl yu dɔktɔ wantɛm wantɛm ɛn mek dɛn no so dat dɛn go advays yu bɔt wetin fɔ du nɛks.

Wetin na di bad tin dɛn we kin apin to pɔsin?

Lɛk ɛni mɛrɛsin, Pembrolizumab kin gɛt sayd ɛfɛkt. Bɔt nɔto ɔlman kin gɛt dɛn. I impɔtant fɔ no bɔt dɛn tin ya. Lɛ wi sheb dɛn tin ya to tu kategori.

Sayd ɛfɛkt we pɔsin kin gɛt Diskripshɔn ɛn wetin fɔ du
Tin dɛn fɔ tɛl yu dɔktɔ wantɛm wantɛm
Alɛji we pɔsin kin gɛt Skin rash, it, swel na di fes, lip ɔ tong.
I nɔ kin izi fɔ yu fɔ blo Kɔf, chɛst pen, i nɔ izi fɔ blo.
Prɔblɛm dɛn we de na di dijestiv sistɛm Bɛlɛ pen bad bad wan, dayarɛa, blɔd na di stɔl, ɔ blak stɔl.
Liva prɔblɛm dɛn di yay ɔ di skin we de yɔlɔ, di urine we dak, pen na di ɔp rayt say na di bɛlɛ, nɔs.
Prɔblɛm dɛn na di kidni di urine autput dεm dεn dכn כ i at fכ urine.
Di shuga na di blɔd we de go ɔp I kin tɔsti bad bad wan, yu mɔt kin dray, yu kin pis bɔku tɛm, ɛn yu kin smɛl lɛk frut.
Ɔda siriɔs sayn dɛn ed we de at bad bad wan, di chenj we yu de si, di jɔyn dɛn de pen, di mɔsul dɛn we wik, di an ɛn fut dɛn we nɔ gɛt bɛtɛ trɛnk, fiva, di limf no dɛn we de swel.
Bɔku tɛm i nɔ kin siriɔs (bɔt tɛl yu dɔktɔ if i kɔntinyu fɔ de) .
We pɔsin taya Di taya we dɛn kin taya ɔltɛm.
Fil fɔ it Di want fɔ it we nɔ de igen.
Di ia we de lɔs Di ia we de lɔs.

Wetin bak a fɔ pe atɛnshɔn to we a de tek dis mɛrɛsin?

Yu dɔktɔ go wach yu sik gud gud wan ɔl di tɛm we yu de trit yu. Yu go nid bak fɔ du blɔd tɛst ɔltɛm (blɔd wok) fɔ si aw di mɛrɛsin de afɛkt yu bɔdi.

Dis rili impɔtant: Yu fɔ avɔyd fɔ gɛt bɛlɛ ɔltogɛda we yu de tek dis mɛrɛsin ɛn fɔ 4 mɔnt afta yu dɔn stɔp fɔ trit yu. Dɔn bak, nɔ fɔ gi pikin in bɛlɛ dis tɛm. Dis kin rili ambɔg di pikin we de na di bɛlɛ. So tɔk to yu dɔktɔ bɔt dis.

Fɔ dɔn, dis mɛrɛsin na fɔ yu nɔmɔ. Nɔ ɛva sheb am wit ɛni ɔda pɔsin.

Mɛsej we dɛn kin kɛr go na os

  • Pembrolizumab na wan mכdan drog we de mek wi bכdi in כwn imyun sistεm fכ atak kansa sεl dεm.
  • Bifo yu bigin fɔ trit yu, i impɔtant fɔ tɛl yu dɔktɔ yu kɔmplit wɛlbɔdi istri, mɔ bɔt ɔda sik dɛn, alɛji, ɛn bɛlɛ.
  • Dɛn kin gi dis mɛrɛsin tru wan vein na ɔspitul. I rili impɔtant fɔ gɛt tritmɛnt di rayt tɛm.
  • I rili impɔtant fɔ avɔyd bɛlɛ ɛn gi pikin in bɛlɛ ɔltogɛda we yu de du di tritmɛnt ɛn fɔ 4 mɔnt afta yu dɔn trit yu.
  • If yu gɛt ɛni siriɔs sayd ɛfɛkt lɛk fɔ mek yu nɔ ebul fɔ blo fayn, yu gɛt bad bad dayarɛa, ɔ yu skin de yɔlɔ, tɛl yu dɔktɔ wantɛm wantɛm.
  • Nɔto yu wan de pan dis waka. Yu dɔktɔ ɛn di mɛdikal tim de wit yu. Nɔ shem fɔ tɔk to dɛn bɔt ɛni kwɛstyɔn ɔ tin we de mɔna yu.

Pembrolizumab, Keytruda, kansa tritmɛnt, kansa mɛrɛsin, monoklɔnal antibodi, imyunotɛrapi, sayd ifɛkt, kansa, kansa tritmɛnt sinhala
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 6 + 5 =
Lɛ wi lan bɔt di Pembrolizumab vaysin we dɛn kin yuz fɔ mɛn kansa.

Lɛ wi lan bɔt di Pembrolizumab vaysin we dɛn kin yuz fɔ mɛn kansa.

We yu kam fɔ no se yu ɔ pɔsin we de nia yu gɛt kansa, i nɔmal fɔ mek yu want fɔ no mɔ bɔt di tritmɛnt dɛn we yu go gɛt, ɛn sɔntɛm yu go ivin fred. I kin mek yu fred, mɔ we yu yɛri bɔt nyu, kɔmplikɛt mɛrɛsin dɛn. Tide wi go tɔk bɔt wan pan dɛn kayn nyu kansa tritmɛnt ya, Pembrolizumab. Lɛ wi tɔk simpul ɛn padi biznɛs bɔt wetin rili de apin ɛn wetin wi nid fɔ no bɔt.

Wetin na Pembrolizumab?

Fɔ tɔk am simpul wan, Pembrolizumab na wan mɛrɛsin we dɛn kin yuz fɔ mɛn sɔm patikyula kayn kansa . Dɛn kɔl am na di makit as ``Keytruda``. dis nכ lεk rεgulεr drog, i de pan wan tכp ``monoclonal antibodi``.

Imajin, wi yon bɔdi gɛt ami we de protɛkt wi frɔm sik, wi de kɔl am di imyun sistɛm. Sɔntɛnde, kansa sɛl dɛn kin rili kɔni, dɛn kin ayd frɔm dis imyun ami. Wetin Pembrolizumab de du na fɔ gi wi imyun sistɛm wan signal, "Wek, ɛnimi de ya," ɛn ɛp am fɔ fɛn kansa sɛl dɛn ɛn atak dɛn. Dat min se na we fɔ yuz wi yon difens sistɛm fɔ fɛt kansa.

Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu bigin tritmɛnt

I rili impɔtant fɔ tɛl yu dɔktɔ bɔt yu kɔmplit wɛlbɔdi histri, bikɔs dis mɛrɛsin nɔr de di sem fɔ ɔlman. Mek shɔ se yu tɛl yu dɔktɔ bɔt dɛn tin ya mɔ:

  • Sik dɛm wae de mek yu imyun sistɛm: If yu gɛt sik dɛm wae de mek yu ebul fɔ fɛt yusɛf, lɛk Crohn’s disease, ulcerative colitis, ɔ lupus, we di bɔdi in imyun sistɛm de atak in yon sɛl dɛm.
  • Ɔgan transplant: If yu dɔn gɛt ɔgan transplant bifo ɔ if yu dɔn gɛt ɔ yu de plan fɔ gɛt allogeneic stem cell transplant.
  • Ɔda mɛrɛsin dɛn: If yu dɔn gɛt raytin tritmɛnt to di chɛst eria, ɔ if yu gɛt wan sik we de na yu nervɔs sistɛm, lɛk myasthenia gravis ɔ Guillain-Barre syndrome.
  • Alɛji: If yu gɛt alɛji to dis mɛrɛsin, Pembrolizumab, ɔ ɛni ɔda mɛrɛsin, it, ɔ day.
  • Bεlε εn bεlε: If yu bεlε, yu de tray fכ bεlε, כ yu de gi pikin bεlε, i fayn fכ tεl yu dכkta. Dis rili impɔtant.

Aw a go gi yu dis mɛrɛsin?

Dis mɛrɛsin nɔto sɔntin we yu kin kɛr go na os.

dis na `infushכn` we dεn de gi insay wan vein, lεk salin. Dat min se na di mɛdikal wokman dɛn we tren na ɔspitul ɔ klinik de gi yu.

Bifo ɛni tritmɛnt sɛshɔn, dɛn go gi yu wan spɛshal infɔmeshɔn liflet (MedGuide) bɔt dis mɛrɛsin. I rili impɔtant fɔ mek yu sef fɔ rid ɛn ɔndastand am gud gud wan ɔltɛm.

Dɛn kin advays dis mɛrɛsin bak fɔ pikin dɛn we dɔn pas 6 mɔnt pan sɔm spɛshal kes dɛm. Bɔt yu fɔ tek tɛm spɛshal, so tek tɛm tɔk bɔt am wit yu dɔktɔ.

Wetin a go du if a tek bɔku mɛrɛsin?

Dis na ɔspitul mɛrɛsin, so di chans fɔ mek dis apin nɔ bɔku. Bɔt if yu tink se yu dɔn tek dis mɛrɛsin tumɔs, go na ɔspitul in Imejɛnsi Yunit (ETU) wantɛm wantɛm . Ɔ kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital fɔ advays.

Wetin a go du if a mis wan tritmɛnt sɛshɔn?

I rili impɔtant fɔ tek dis mɛrɛsin di de ɛn tɛm we dɛn dɔn sɛtul. If yu nɔ ebul fɔ go na ɔspitul di de we dɛn dɔn plan fɔ go, kɔl yu dɔktɔ wantɛm wantɛm ɛn mek dɛn no so dat dɛn go advays yu bɔt wetin fɔ du nɛks.

Wetin na di bad tin dɛn we kin apin to pɔsin?

Lɛk ɛni mɛrɛsin, Pembrolizumab kin gɛt sayd ɛfɛkt. Bɔt nɔto ɔlman kin gɛt dɛn. I impɔtant fɔ no bɔt dɛn tin ya. Lɛ wi sheb dɛn tin ya to tu kategori.

Sayd ɛfɛkt we pɔsin kin gɛt Diskripshɔn ɛn wetin fɔ du
Tin dɛn fɔ tɛl yu dɔktɔ wantɛm wantɛm
Alɛji we pɔsin kin gɛt Skin rash, it, swel na di fes, lip ɔ tong.
I nɔ kin izi fɔ yu fɔ blo Kɔf, chɛst pen, i nɔ izi fɔ blo.
Prɔblɛm dɛn we de na di dijestiv sistɛm Bɛlɛ pen bad bad wan, dayarɛa, blɔd na di stɔl, ɔ blak stɔl.
Liva prɔblɛm dɛn di yay ɔ di skin we de yɔlɔ, di urine we dak, pen na di ɔp rayt say na di bɛlɛ, nɔs.
Prɔblɛm dɛn na di kidni di urine autput dεm dεn dכn כ i at fכ urine.
Di shuga na di blɔd we de go ɔp I kin tɔsti bad bad wan, yu mɔt kin dray, yu kin pis bɔku tɛm, ɛn yu kin smɛl lɛk frut.
Ɔda siriɔs sayn dɛn ed we de at bad bad wan, di chenj we yu de si, di jɔyn dɛn de pen, di mɔsul dɛn we wik, di an ɛn fut dɛn we nɔ gɛt bɛtɛ trɛnk, fiva, di limf no dɛn we de swel.
Bɔku tɛm i nɔ kin siriɔs (bɔt tɛl yu dɔktɔ if i kɔntinyu fɔ de) .
We pɔsin taya Di taya we dɛn kin taya ɔltɛm.
Fil fɔ it Di want fɔ it we nɔ de igen.
Di ia we de lɔs Di ia we de lɔs.

Wetin bak a fɔ pe atɛnshɔn to we a de tek dis mɛrɛsin?

Yu dɔktɔ go wach yu sik gud gud wan ɔl di tɛm we yu de trit yu. Yu go nid bak fɔ du blɔd tɛst ɔltɛm (blɔd wok) fɔ si aw di mɛrɛsin de afɛkt yu bɔdi.

Dis rili impɔtant: Yu fɔ avɔyd fɔ gɛt bɛlɛ ɔltogɛda we yu de tek dis mɛrɛsin ɛn fɔ 4 mɔnt afta yu dɔn stɔp fɔ trit yu. Dɔn bak, nɔ fɔ gi pikin in bɛlɛ dis tɛm. Dis kin rili ambɔg di pikin we de na di bɛlɛ. So tɔk to yu dɔktɔ bɔt dis.

Fɔ dɔn, dis mɛrɛsin na fɔ yu nɔmɔ. Nɔ ɛva sheb am wit ɛni ɔda pɔsin.

Mɛsej we dɛn kin kɛr go na os

  • Pembrolizumab na wan mכdan drog we de mek wi bכdi in כwn imyun sistεm fכ atak kansa sεl dεm.
  • Bifo yu bigin fɔ trit yu, i impɔtant fɔ tɛl yu dɔktɔ yu kɔmplit wɛlbɔdi istri, mɔ bɔt ɔda sik dɛn, alɛji, ɛn bɛlɛ.
  • Dɛn kin gi dis mɛrɛsin tru wan vein na ɔspitul. I rili impɔtant fɔ gɛt tritmɛnt di rayt tɛm.
  • I rili impɔtant fɔ avɔyd bɛlɛ ɛn gi pikin in bɛlɛ ɔltogɛda we yu de du di tritmɛnt ɛn fɔ 4 mɔnt afta yu dɔn trit yu.
  • If yu gɛt ɛni siriɔs sayd ɛfɛkt lɛk fɔ mek yu nɔ ebul fɔ blo fayn, yu gɛt bad bad dayarɛa, ɔ yu skin de yɔlɔ, tɛl yu dɔktɔ wantɛm wantɛm.
  • Nɔto yu wan de pan dis waka. Yu dɔktɔ ɛn di mɛdikal tim de wit yu. Nɔ shem fɔ tɔk to dɛn bɔt ɛni kwɛstyɔn ɔ tin we de mɔna yu.

Pembrolizumab, Keytruda, kansa tritmɛnt, kansa mɛrɛsin, monoklɔnal antibodi, imyunotɛrapi, sayd ifɛkt, kansa, kansa tritmɛnt sinhala
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 6 + 5 =